Back to search

Netherlands· NL-8783a70908c2

Fevarin 100, filmomhulde tabletten

A fluvoxamine product containing fluvoxaminewaterstofmaleaat, registered in Netherlands by Viatris Healthcare Limited. The same ATC class is registered in 17 of our 19 countries.

ATC N06AB08

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFevarin 100, filmomhulde tablettenATCN06AB08REGISTER NO.NL-8783a70908c2PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Fluvoxamine is registered in 17 of 19 countries.

Countries holding a registration under ATC N06AB08 (fluvoxamine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Fluvoxamine · ATC N06AB08

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fluvoxamine costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.25 in France to $1.43 in Switzerland — a ×5.6 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Fluvoxamine · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.43
  • IT Italy$0.40
  • ES Spain$0.29
  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FLUVOXAMINEWATERSTOFMALEAAT
Manufacturer
Viatris Healthcare Limited
Country
Netherlands (NL)
ATC code
N06AB08
ATC class
Fluvoxamine
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    11619

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

450 interactions on record for fluvoxamine.

Graded by severity as the source publishes them — 38 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fluvoxamine · interactions on record

450 records

  • 38 severe
  • 313 moderate
  • 8 minor
  • 14 info

Most severe, free to view

  • AlosetronA03AE01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

77 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fluvoxamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluvoxamine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Floxyfral
  • Belgium · Floxyfral, Fluvoxamine Eg
  • Bulgaria · Феварин
  • Cyprus · Faverin
  • Czechia · Fevarin
  • Germany · Fevarin, Fluvoxamin Neuraxpharm
  • Estonia · Fevarin
  • Spain · Dumirox, Fluvoxamina Sandoz
  • Finland · Fluvosol
  • France · Floxyfral, Fluvoxamine Arrow
  • United Kingdom (Northern Ireland) · Faverin, Fluvoxamine Tillomed Laboratories
  • Greece · Dumyrox
  • Croatia · Fevarin
  • Hungary · Fevarin
  • Ireland · Faverin
  • Italy · Dumirox, Fevarin
  • Lithuania · Fevarin
  • Luxembourg · Floxyfral, Fluvoxamine Eg
  • Latvia · Fevarin
  • Malta · Dumyrox
  • Norway · Fevarin
  • Poland · Fevarin
  • Portugal · Dumyrox, Fluvoxamina Generis
  • Romania · Fevarin
  • Sweden · Fevarin
  • Slovakia · Fevarin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/242ecdfe-6b97-4d83-aa99-1781a6f432f7
GET /v1/drugs/242ecdfe-6b97-4d83-aa99-1781a6f432f7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h11619_smpc.pdf",
  "strength": null,
  "atc_label": "Fluvoxamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg11619",
  "excipients": [
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MACROGOL 6000",
    "MANNITOL (D-) (E 421)",
    "MAÏSZETMEEL",
    "NATRIUMSTEARYLFUMARAAT",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "FLUVOXAMINEWATERSTOFMALEAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h11619.pdf",
  "authorised_at": "1986/01/28",
  "procedure_number": "DE/H/5314/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "11619",
  "additional_monitoring": "N"
}

See everything about fluvoxamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.